Unveiling the New Trick for Epigenetic Drug: Radiation Enhancement of Prostate Cancer by the EZH2 Inhibitor Tazemetostat.
- DOI
- 10.1111/jcmm.71330
- Published
- 2026 Aug
- Container
- Journal of cellular and molecular medicine
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1111/jcmm.71330,
title = {Unveiling the New Trick for Epigenetic Drug: Radiation Enhancement of Prostate Cancer by the EZH2 Inhibitor Tazemetostat.},
author = {Du TQ and Ou Y and Liu RJ and Feng Y and Li Y and Chen G and Wu X},
year = {2026},
journal = {Journal of cellular and molecular medicine},
doi = {10.1111/jcmm.71330},
url = {https://doi.org/10.1111/jcmm.71330}
}RIS
TY - JOUR TI - Unveiling the New Trick for Epigenetic Drug: Radiation Enhancement of Prostate Cancer by the EZH2 Inhibitor Tazemetostat. AU - Du TQ AU - Ou Y AU - Liu RJ AU - Feng Y AU - Li Y AU - Chen G AU - Wu X PY - 2026 JO - Journal of cellular and molecular medicine DO - 10.1111/jcmm.71330 UR - https://doi.org/10.1111/jcmm.71330 ER -
APA
TQ, D., Y, O., RJ, L., Y, F., Y, L., G, C., & X, W. (2026). Unveiling the New Trick for Epigenetic Drug: Radiation Enhancement of Prostate Cancer by the EZH2 Inhibitor Tazemetostat.. Journal of cellular and molecular medicine. https://doi.org/10.1111/jcmm.71330
Source records
- pubmed · retrieved 2026-09-25T11:03:56.731Z